Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 493

1.

Clinical and operational value of the extensively drug-resistant tuberculosis definition.

Migliori GB, Besozzi G, Girardi E, Kliiman K, Lange C, Toungoussova OS, Ferrara G, Cirillo DM, Gori A, Matteelli A, Spanevello A, Codecasa LR, Raviglione MC; SMIRA/TBNET Study Group.

Eur Respir J. 2007 Oct;30(4):623-6. Epub 2007 Aug 9.

2.

Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases.

Migliori GB, Lange C, Centis R, Sotgiu G, Mütterlein R, Hoffmann H, Kliiman K, De Iaco G, Lauria FN, Richardson MD, Spanevello A, Cirillo DM; TBNET Study Group.

Eur Respir J. 2008 Jun;31(6):1155-9. doi: 10.1183/09031936.00028708.

3.

Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.

Park SK, Kim JH, Kang H, Cho JS, Smego RA Jr.

Int J Infect Dis. 2009 Mar;13(2):170-5. doi: 10.1016/j.ijid.2008.06.001. Epub 2008 Sep 2.

4.

Drug-resistant tuberculosis in the WHO European Region: an analysis of surveillance data.

Zignol M, Dara M, Dean AS, Falzon D, Dadu A, Kremer K, Hoffmann H, Hoffner S, Floyd K.

Drug Resist Updat. 2013 Dec;16(6):108-15. doi: 10.1016/j.drup.2014.02.003. Epub 2014 Feb 28. Review.

5.
6.

Incidence and risk factors for extensively drug-resistant tuberculosis in Delhi region.

Porwal C, Kaushik A, Makkar N, Banavaliker JN, Hanif M, Singla R, Bhatnagar AK, Behera D, Pande JN, Singh UB.

PLoS One. 2013;8(2):e55299. doi: 10.1371/journal.pone.0055299. Epub 2013 Feb 4.

7.

Extensively drug-resistant tuberculosis in california, 1993-2006.

Banerjee R, Allen J, Westenhouse J, Oh P, Elms W, Desmond E, Nitta A, Royce S, Flood J.

Clin Infect Dis. 2008 Aug 15;47(4):450-7. doi: 10.1086/590009.

PMID:
18616396
8.

Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.

Ramachandran R, Nalini S, Chandrasekar V, Dave PV, Sanghvi AS, Wares F, Paramasivan CN, Narayanan PR, Sahu S, Parmar M, Chadha S, Dewan P, Chauhan LS.

Int J Tuberc Lung Dis. 2009 Sep;13(9):1154-60.

PMID:
19723407
9.

Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions.

Prasad R.

Indian J Tuberc. 2010 Oct;57(4):180-91. Review.

PMID:
21141336
10.

Problems of multidrug- and extensively drug-resistant TB.

[No authors listed]

Drug Ther Bull. 2012 Feb;50(2):21-4. doi: 10.1136/dtb.2012.02.0087.

PMID:
22329954
11.

New treatment options for multidrug-resistant tuberculosis.

Field SK, Fisher D, Jarand JM, Cowie RL.

Ther Adv Respir Dis. 2012 Oct;6(5):255-68. Epub 2012 Jul 4. Review.

PMID:
22763676
12.

Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012.

Chang KC, Yew WW.

Respirology. 2013 Jan;18(1):8-21. doi: 10.1111/j.1440-1843.2012.02257.x. Review.

13.

Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.

Lai CC, Tan CK, Huang YT, Chou CH, Hung CC, Yang PC, Luh KT, Hsueh PR.

Clin Infect Dis. 2008 Oct 1;47(7):e57-63. doi: 10.1086/591702.

PMID:
18715157
14.

Extensively drug-resistant tuberculosis at a tuberculosis specialist hospital in Shanghai, China: clinical characteristics and treatment outcomes.

Tang S, Zhang Q, Yu J, Liu Y, Sha W, Sun H, Fan L, Gu J, Hao X, Yao L, Xiao H.

Scand J Infect Dis. 2011 Apr;43(4):280-5. doi: 10.3109/00365548.2010.548080. Epub 2011 Jan 19.

PMID:
21247226
15.

Multidrug- and extensively drug-resistant tuberculosis, Germany.

Eker B, Ortmann J, Migliori GB, Sotgiu G, Muetterlein R, Centis R, Hoffmann H, Kirsten D, Schaberg T, Ruesch-Gerdes S, Lange C; German TBNET Group.

Emerg Infect Dis. 2008 Nov;14(11):1700-6. doi: 10.3201/eid1411.080729.

16.

Extensively drug-resistant tuberculosis: current challenges and threats.

Jain A, Mondal R.

FEMS Immunol Med Microbiol. 2008 Jul;53(2):145-50. doi: 10.1111/j.1574-695X.2008.00400.x. Epub 2008 May 8. Review.

18.

Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.

Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2009 Feb 13;58(RR-3):1-43.

19.

Surveillance of extensively drug-resistant tuberculosis in Europe, 2003-2007.

Devaux I, Manissero D, Fernandez de la Hoz K, Kremer K, van Soolingen D; EuroTB network.

Euro Surveill. 2010 Mar 18;15(11). pii: 19518.

20.

Multidrug-resistant and extensively drug-resistant tuberculosis in multi-ethnic region, Xinjiang Uygur Autonomous Region, China.

Qi YC, Ma MJ, Li DJ, Chen MJ, Lu QB, Li XJ, Li JL, Liu W, Cao WC.

PLoS One. 2012;7(2):e32103. doi: 10.1371/journal.pone.0032103. Epub 2012 Feb 22.

Supplemental Content

Support Center